Rahsaan Thompson's Insider Trades & SAST Disclosures
Rahsaan Thompson's most recent trade in Zevra Therapeutics Inc was a trade of 68,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rahsaan Thompson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Rahsaan W. Thompson | Chief Legal & Compliance, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 68,000 | 68,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Rahsaan W. Thompson | Chief Legal & Compliance, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 34,000 | 34,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Rahsaan W. Thompson | Chief Legal & Compliance, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Lyell Immunopharma Inc | Rahsaan Thompson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 245,000 | 245,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Rahsaan Thompson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 715,000 | 715,000 | - | - | Option (right to buy) | |
| Gritstone Bio Inc | Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 115,440 | 115,440 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 19,240 | 58,698 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Rahsaan Thompson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 25,500 | 29,487 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges